A Single-blinded, Controlled, Multi-centre Study of Effects of Exercise in Participants With Multiple Sclerosis

NCT ID: NCT01065090

Last Updated: 2015-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

38 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-06-30

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of the investigation is to determine whether the addition of exercise (resistance training or modified physiotherapy) improves functional capacity in Multiple Sclerosis (MS) participants undergoing Disease Modifying Therapy (DMT) treatment. We hypothesize that the Progressive Resistance Training (PRT) will improve functional capacity without increasing the risk of relapses in participants undergoing standard DMT treatment. The secondary objectives are to determine whether exercise (resistance training or physiotherapy) improves fatigue, mood and Quality of Life (QoL) in MS participants undergoing DMT treatment. Also as a secondary objective, the study aims at determining whether exercise (resistance training or modified physiotherapy) has an impact on Expanded Disability Status Scale (EDSS), time to first relapse, number of relapse free participants, and immunological factors. We hypothesize that the exercise (resistance training) will improve fatigue, mood and QoL and that an impact on immunological factors will be seen in participants even though they are undergoing standard DMT treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

training

one group will receive resistance training and one group the normal physiotherapeutic treatment

No interventions assigned to this group

physiotherapy

one group will receive resistance training and one group the normal physiotherapeutic treatment

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \> 18 years and age \< 65 years at screening
* Relapsing Remitting Multiple Sclerosis (RRMS) diagnosis according to McDonald Criteria
* Subjects who have been on Avonex treatment for 3-6 months prior to screening
* A signed informed consent form (ICF) is obtained before any study activity
* EDSS \> 1.5 and \< 5 at Screening with at least a score of 1 in pyramidal function
* Are able to walk at least 100 meters
* Are able to transport themselves to and from the training facility

Exclusion Criteria

* Suffer from dementia, alcoholism or if they use pacemaker
* Have any serious medical co-morbidities like cardiovascular, respiratory, orthopedic or metabolic diseases
* Have had a MS relapse within an eight week period prior to the study start
* Are pregnant
* Have trained systematic resistance training for one day or more each week in the prior 3 months before study start.
* Only able to participate in less than 70% of the planned training sessions.
* Suffers from major depression
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biogen Idec A/S

UNKNOWN

Sponsor Role collaborator

Biogen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Director

Role: STUDY_DIRECTOR

Biogen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Coordinating Research Site

NSW, , Australia

Site Status

Research Site

Odense, , Denmark

Site Status

Research Site

Sønderborg, , Denmark

Site Status

Research Site

Vejle, , Denmark

Site Status

Research Site

Jyväskylä, , Finland

Site Status

Research Site

Oulu, , Finland

Site Status

Research Site

Pori, , Finland

Site Status

Research Site

Seinäjokï, , Finland

Site Status

Research Site

Hamilton, , New Zealand

Site Status

Research Site

Drammen, , Norway

Site Status

Research Site

Ullevål, , Norway

Site Status

Research Site

Ängelholm, , Sweden

Site Status

Research Site

Gothenburg, , Sweden

Site Status

Research Site

Stockholm, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia Denmark Finland New Zealand Norway Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ACTIMS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise in Multiple Sclerosis
NCT02716701 TERMINATED NA
Exercise and Brain Health in MS
NCT03638739 COMPLETED NA